Institute of Infection and Global Health, University of Liverpool, Leahurst Campus, Neston, Cheshire CH64 7TE, UK.
Boehringer Ingelheim, 69007 Lyon, 29 avenue Tony Garnier, France.
Vaccine. 2019 Dec 10;37(52):7566-7575. doi: 10.1016/j.vaccine.2019.09.081. Epub 2019 Oct 10.
This study reports on the simultaneous administration of live NDV or aMPV subtype B vaccines alongside two live IBV (Massachusetts-H120 and 793B-CR88) vaccines in day-old maternal-antibody positive commercial broiler chicks. In the first experiment, chicks were divided into four groups; one unvaccinated and three groups vaccinated with live NDV VG/GA-Avinew, live H120 + CR88, or VG/GA-Avinew + H120 + CR88. In the second experiment, live aMPV subtype B vaccine was used in place of NDV. Clinical signs were monitored daily and oropharyngeal swabs were taken at regular intervals for vaccine virus detection. Blood was collected at 21 dpv for serology. 10 chicks from each group were challenged with virulent strains of M41 or QX or aMPV subtype B. For IBV, after 5 days post challenge (dpc), tracheal ciliary protection was assessed. For aMPV, clinical scores were recorded up to 10 dpc. For NDV, haemagglutination inhibition (HI) antibody titres were assayed as an indicator of protective immunity. In both experiments, ciliary protection for IBV vaccinated groups was maintained above 90%. The protection against virulent aMPV challenge was not compromised when aMPV, H120 and CR88 were co-administered. NDV HI mean titres in single and combined NDV-vaccinated groups remained above the protective titre (>3 log). Both experiments demonstrated that simultaneous administration of live NDV VG/GA-Avinew or aMPV subtype B alongside H120 and CR88 vaccines does not interfere with protection conferred against NDV, IBV or aMPV.
本研究报告了在母源抗体阳性的商业肉鸡雏鸡中同时接种活新城疫病毒(NDV)或 aMPV 亚型 B 疫苗以及两种活传染性支气管炎病毒(IBV)(马萨诸塞州-H120 和 793B-CR88)疫苗的情况。在第一个实验中,将雏鸡分为四组;一组未接种疫苗,三组分别接种活 NDV VG/GA-Avinew、活 H120+CR88 或 VG/GA-Avinew+H120+CR88。在第二个实验中,活 aMPV 亚型 B 疫苗代替了 NDV。每天监测临床症状,并定期采集口咽拭子以检测疫苗病毒。在 21 日龄时采集血液进行血清学检测。每组 10 只雏鸡用强毒 M41 或 QX 或 aMPV 亚型 B 进行攻毒。对于 IBV,攻毒后 5 天(dpc)评估气管纤毛保护。对于 aMPV,记录临床评分至 10 dpc。对于 NDV,血凝抑制(HI)抗体滴度作为保护性免疫的指标进行测定。在两个实验中,接种 IBV 的各组的纤毛保护均保持在 90%以上。当同时接种 aMPV、H120 和 CR88 时,不会影响对强毒 aMPV 攻毒的保护。在单独和联合接种 NDV 疫苗的组中,NDV HI 平均滴度均保持在保护性滴度(>3 log)以上。两个实验均表明,同时接种活新城疫病毒 VG/GA-Avinew 或 aMPV 亚型 B 以及 H120 和 CR88 疫苗不会干扰对 NDV、IBV 或 aMPV 的保护。